The Improvement of the Dissolution Rate of Ziprasidone Free Base from Solid Oral Formulations View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-08

AUTHORS

Daniel Zakowiecki, Krzysztof Cal, Kamil Kaminski, Karolina Adrjanowicz, Lech Swinder, Ewa Kaminska, Grzegorz Garbacz

ABSTRACT

This work aims at increasing solubility and dissolution rate of ziprasidone free base-Biopharmaceutics Classifaction System (BCS) class II compound. The authors describe a practical approach to amorphization and highlight problems that may occur during the development of formulations containing amorphous ziprasidone, which was obtained by grinding in high-energy planetary ball mills or cryogenic mills. The release of ziprasidone free base from the developed formulations was compared to the reference drug product containing crystalline ziprasidone hydrochloride-Zeldox® hard gelatin capsules. All preparations were investigated using compendial tests (USP apparatuses II and IV) as well as novel, biorelevant dissolution tests. The novel test methods simulate additional elements of mechanical and hydrodynamic stresses, which have an impact on solid oral dosage forms, especially during gastric emptying. This step may prove to be particularly important for many formulations of BCS class II drugs that are often characterized by narrow absorption window, such as ziprasidone. The dissolution rate of the developed ziprasidone free base preparations was found to be comparable or even higher than in the case of the reference formulation containing ziprasidone hydrochloride, whose water solubility is about 400 times higher than its free base. More... »

PAGES

922-933

Identifiers

URI

http://scigraph.springernature.com/pub.10.1208/s12249-015-0285-1

DOI

http://dx.doi.org/10.1208/s12249-015-0285-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000072866

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25588366


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemistry, Pharmaceutical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piperazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Powder Diffraction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Solubility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiazoles", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Pharmaceutical Works Polpharma SA, Pelplinska 19, 83-200, Starogard Gdanski, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zakowiecki", 
        "givenName": "Daniel", 
        "id": "sg:person.01017515061.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017515061.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gda\u0144sk Medical University", 
          "id": "https://www.grid.ac/institutes/grid.11451.30", 
          "name": [
            "Department of Pharmaceutical Technology, Medical University of Gdansk, Hallera 107, 80-416, Gdansk, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cal", 
        "givenName": "Krzysztof", 
        "id": "sg:person.01045124573.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045124573.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Silesia", 
          "id": "https://www.grid.ac/institutes/grid.11866.38", 
          "name": [
            "Institute of Physics, University of Silesia, Uniwersytecka 4, 40-007, Katowice, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaminski", 
        "givenName": "Kamil", 
        "id": "sg:person.01200213234.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200213234.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Adam Mickiewicz University in Pozna\u0144", 
          "id": "https://www.grid.ac/institutes/grid.5633.3", 
          "name": [
            "NanoBioMedical Centre, Adam Mickiewicz University, Umultowska 85, 61-614, Poznan, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adrjanowicz", 
        "givenName": "Karolina", 
        "id": "sg:person.01036143544.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036143544.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Pharmaceutical Works Polpharma SA, Pelplinska 19, 83-200, Starogard Gdanski, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Swinder", 
        "givenName": "Lech", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical University of Silesia", 
          "id": "https://www.grid.ac/institutes/grid.411728.9", 
          "name": [
            "Department of Pharmacognosy and Phytochemistry, Medical University of Silesia in Katowice, ul. Jagiellonska 4, 41-200, Sosnowiec, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaminska", 
        "givenName": "Ewa", 
        "id": "sg:person.01177540504.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177540504.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Greifswald", 
          "id": "https://www.grid.ac/institutes/grid.5603.0", 
          "name": [
            "Institute of Pharmacy, University of Greifswald, Felix-Hausdorf-Strasse 3a, 17489, Greifswald, Germany", 
            "Physiolution GmbH, Walther-Rathenau-Strasse 49 a, 17489, Greifswald, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garbacz", 
        "givenName": "Grzegorz", 
        "id": "sg:person.01304442051.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304442051.71"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1021/js9601896", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003304858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-010-0269-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004044325", 
          "https://doi.org/10.1007/s11095-010-0269-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-010-0269-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004044325", 
          "https://doi.org/10.1007/s11095-010-0269-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/17425247.2010.527943", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007294236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/03639040903311081", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009118497"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/14786435.2010.534742", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011684960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejps.2009.06.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011938329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00023210-200317060-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013429957", 
          "https://doi.org/10.2165/00023210-200317060-00004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00023210-200317060-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013429957", 
          "https://doi.org/10.2165/00023210-200317060-00004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1039/c3cp52643g", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015773196"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1007516718048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017094560", 
          "https://doi.org/10.1023/a:1007516718048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.21799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019762655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2008.05.029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026516251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejps.2013.08.039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039065309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-011-0496-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047079674", 
          "https://doi.org/10.1007/s11095-011-0496-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/9783527623860.ch19", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047281475"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200847100-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047478348", 
          "https://doi.org/10.2165/00003088-200847100-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0378-5173(98)00338-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050042406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.22479", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051977655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp300067r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056212845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp300606p", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056213140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/blr.2006.25.447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059238419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1358/dof.1994.019.06.254341", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1065060842"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.14227/dt160209p6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067217438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077518548", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078633835", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/001857870103600612", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100243706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/001857870103600612", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100243706"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-08", 
    "datePublishedReg": "2015-08-01", 
    "description": "This work aims at increasing solubility and dissolution rate of ziprasidone free base-Biopharmaceutics Classifaction System (BCS) class II compound. The authors describe a practical approach to amorphization and highlight problems that may occur during the development of formulations containing amorphous ziprasidone, which was obtained by grinding in high-energy planetary ball mills or cryogenic mills. The release of ziprasidone free base from the developed formulations was compared to the reference drug product containing crystalline ziprasidone hydrochloride-Zeldox\u00ae hard gelatin capsules. All preparations were investigated using compendial tests (USP apparatuses II and IV) as well as novel, biorelevant dissolution tests. The novel test methods simulate additional elements of mechanical and hydrodynamic stresses, which have an impact on solid oral dosage forms, especially during gastric emptying. This step may prove to be particularly important for many formulations of BCS class II drugs that are often characterized by narrow absorption window, such as ziprasidone. The dissolution rate of the developed ziprasidone free base preparations was found to be comparable or even higher than in the case of the reference formulation containing ziprasidone hydrochloride, whose water solubility is about 400 times higher than its free base. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1208/s12249-015-0285-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1023420", 
        "issn": [
          "1530-9932"
        ], 
        "name": "AAPS PharmSciTech", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "The Improvement of the Dissolution Rate of Ziprasidone Free Base from Solid Oral Formulations", 
    "pagination": "922-933", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0058c7ab07d00cb646663687ae38235ca64838f4b12a94b2ff05581d00e40723"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25588366"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100960111"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1208/s12249-015-0285-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000072866"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1208/s12249-015-0285-1", 
      "https://app.dimensions.ai/details/publication/pub.1000072866"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000498.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1208/s12249-015-0285-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1208/s12249-015-0285-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1208/s12249-015-0285-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1208/s12249-015-0285-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1208/s12249-015-0285-1'


 

This table displays all metadata directly associated to this object as RDF triples.

228 TRIPLES      21 PREDICATES      60 URIs      27 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1208/s12249-015-0285-1 schema:about N0d0f49b4c14b4e3ea5bae8110766a33f
2 N3e659c89e49542199e332c7390bdc104
3 N7b4d387f091c42a3a7a4f977c6a2fadd
4 N96eba9bcc5404308aaabb01ae7a495ef
5 N98aef22bdfa6463ab7c73d8086e796a2
6 Nd31666d69f884e2db490fcb7986a2acb
7 anzsrc-for:03
8 anzsrc-for:0306
9 schema:author Nf41c4aecceb94517a037229409286e64
10 schema:citation sg:pub.10.1007/s11095-010-0269-5
11 sg:pub.10.1007/s11095-011-0496-4
12 sg:pub.10.1023/a:1007516718048
13 sg:pub.10.2165/00003088-200847100-00003
14 sg:pub.10.2165/00023210-200317060-00004
15 https://app.dimensions.ai/details/publication/pub.1077518548
16 https://app.dimensions.ai/details/publication/pub.1078633835
17 https://doi.org/10.1002/9783527623860.ch19
18 https://doi.org/10.1002/jps.21799
19 https://doi.org/10.1002/jps.22479
20 https://doi.org/10.1016/j.ejpb.2008.05.029
21 https://doi.org/10.1016/j.ejps.2009.06.010
22 https://doi.org/10.1016/j.ejps.2013.08.039
23 https://doi.org/10.1016/s0378-5173(98)00338-x
24 https://doi.org/10.1021/js9601896
25 https://doi.org/10.1021/mp300067r
26 https://doi.org/10.1021/mp300606p
27 https://doi.org/10.1039/c3cp52643g
28 https://doi.org/10.1080/14786435.2010.534742
29 https://doi.org/10.1089/blr.2006.25.447
30 https://doi.org/10.1177/001857870103600612
31 https://doi.org/10.1358/dof.1994.019.06.254341
32 https://doi.org/10.14227/dt160209p6
33 https://doi.org/10.1517/17425247.2010.527943
34 https://doi.org/10.3109/03639040903311081
35 schema:datePublished 2015-08
36 schema:datePublishedReg 2015-08-01
37 schema:description This work aims at increasing solubility and dissolution rate of ziprasidone free base-Biopharmaceutics Classifaction System (BCS) class II compound. The authors describe a practical approach to amorphization and highlight problems that may occur during the development of formulations containing amorphous ziprasidone, which was obtained by grinding in high-energy planetary ball mills or cryogenic mills. The release of ziprasidone free base from the developed formulations was compared to the reference drug product containing crystalline ziprasidone hydrochloride-Zeldox® hard gelatin capsules. All preparations were investigated using compendial tests (USP apparatuses II and IV) as well as novel, biorelevant dissolution tests. The novel test methods simulate additional elements of mechanical and hydrodynamic stresses, which have an impact on solid oral dosage forms, especially during gastric emptying. This step may prove to be particularly important for many formulations of BCS class II drugs that are often characterized by narrow absorption window, such as ziprasidone. The dissolution rate of the developed ziprasidone free base preparations was found to be comparable or even higher than in the case of the reference formulation containing ziprasidone hydrochloride, whose water solubility is about 400 times higher than its free base.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree true
41 schema:isPartOf N413a0acba06642fbb033908261e65cd5
42 Ndfb8d86104c14f5cb5bd3a99c679d803
43 sg:journal.1023420
44 schema:name The Improvement of the Dissolution Rate of Ziprasidone Free Base from Solid Oral Formulations
45 schema:pagination 922-933
46 schema:productId N4d03886363e94eb5a6cf618dc4285e45
47 N9343c11ead204c4f9f296408155dca74
48 N98cf218037d34f98a8375d64533a46bf
49 Nd0b7d88ef9fa467e8d772fec67852df0
50 Ne7f404e1e4a743afa44fd9f59626aab7
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000072866
52 https://doi.org/10.1208/s12249-015-0285-1
53 schema:sdDatePublished 2019-04-10T16:39
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N738dfcfd761044d2a9146107758a90e6
56 schema:url http://link.springer.com/10.1208/s12249-015-0285-1
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N04c92ddd1e7e4d22a3ea620a93d1098d rdf:first sg:person.01177540504.39
61 rdf:rest Nfa4dfa4ff09b4c17840d909de3ba8b7b
62 N0d0f49b4c14b4e3ea5bae8110766a33f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Chemistry, Pharmaceutical
64 rdf:type schema:DefinedTerm
65 N3e659c89e49542199e332c7390bdc104 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Administration, Oral
67 rdf:type schema:DefinedTerm
68 N413a0acba06642fbb033908261e65cd5 schema:volumeNumber 16
69 rdf:type schema:PublicationVolume
70 N4d03886363e94eb5a6cf618dc4285e45 schema:name pubmed_id
71 schema:value 25588366
72 rdf:type schema:PropertyValue
73 N569140654b864862974820f15deef63b schema:affiliation N603a4faaee384936af7a7578e5af2d94
74 schema:familyName Swinder
75 schema:givenName Lech
76 rdf:type schema:Person
77 N603a4faaee384936af7a7578e5af2d94 schema:name Pharmaceutical Works Polpharma SA, Pelplinska 19, 83-200, Starogard Gdanski, Poland
78 rdf:type schema:Organization
79 N6f74c3ac1a9d4bb28c2dbedb80819211 rdf:first sg:person.01045124573.31
80 rdf:rest Nfb303c50520f445da6dba29422c438b1
81 N738dfcfd761044d2a9146107758a90e6 schema:name Springer Nature - SN SciGraph project
82 rdf:type schema:Organization
83 N7b4d387f091c42a3a7a4f977c6a2fadd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Powder Diffraction
85 rdf:type schema:DefinedTerm
86 N85003740b73d4307814901fb223f4840 rdf:first N569140654b864862974820f15deef63b
87 rdf:rest N04c92ddd1e7e4d22a3ea620a93d1098d
88 N9343c11ead204c4f9f296408155dca74 schema:name readcube_id
89 schema:value 0058c7ab07d00cb646663687ae38235ca64838f4b12a94b2ff05581d00e40723
90 rdf:type schema:PropertyValue
91 N96eba9bcc5404308aaabb01ae7a495ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Thiazoles
93 rdf:type schema:DefinedTerm
94 N98aef22bdfa6463ab7c73d8086e796a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Piperazines
96 rdf:type schema:DefinedTerm
97 N98cf218037d34f98a8375d64533a46bf schema:name dimensions_id
98 schema:value pub.1000072866
99 rdf:type schema:PropertyValue
100 Nbf655734517c437a82967c23f6d8b02a rdf:first sg:person.01036143544.73
101 rdf:rest N85003740b73d4307814901fb223f4840
102 Nd0b7d88ef9fa467e8d772fec67852df0 schema:name nlm_unique_id
103 schema:value 100960111
104 rdf:type schema:PropertyValue
105 Nd31666d69f884e2db490fcb7986a2acb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Solubility
107 rdf:type schema:DefinedTerm
108 Ndfb8d86104c14f5cb5bd3a99c679d803 schema:issueNumber 4
109 rdf:type schema:PublicationIssue
110 Ne7f404e1e4a743afa44fd9f59626aab7 schema:name doi
111 schema:value 10.1208/s12249-015-0285-1
112 rdf:type schema:PropertyValue
113 Neab517190aba4bd4b0945d2395ab8a61 schema:name Pharmaceutical Works Polpharma SA, Pelplinska 19, 83-200, Starogard Gdanski, Poland
114 rdf:type schema:Organization
115 Nf41c4aecceb94517a037229409286e64 rdf:first sg:person.01017515061.47
116 rdf:rest N6f74c3ac1a9d4bb28c2dbedb80819211
117 Nfa4dfa4ff09b4c17840d909de3ba8b7b rdf:first sg:person.01304442051.71
118 rdf:rest rdf:nil
119 Nfb303c50520f445da6dba29422c438b1 rdf:first sg:person.01200213234.22
120 rdf:rest Nbf655734517c437a82967c23f6d8b02a
121 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
122 schema:name Chemical Sciences
123 rdf:type schema:DefinedTerm
124 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
125 schema:name Physical Chemistry (incl. Structural)
126 rdf:type schema:DefinedTerm
127 sg:journal.1023420 schema:issn 1530-9932
128 schema:name AAPS PharmSciTech
129 rdf:type schema:Periodical
130 sg:person.01017515061.47 schema:affiliation Neab517190aba4bd4b0945d2395ab8a61
131 schema:familyName Zakowiecki
132 schema:givenName Daniel
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017515061.47
134 rdf:type schema:Person
135 sg:person.01036143544.73 schema:affiliation https://www.grid.ac/institutes/grid.5633.3
136 schema:familyName Adrjanowicz
137 schema:givenName Karolina
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036143544.73
139 rdf:type schema:Person
140 sg:person.01045124573.31 schema:affiliation https://www.grid.ac/institutes/grid.11451.30
141 schema:familyName Cal
142 schema:givenName Krzysztof
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045124573.31
144 rdf:type schema:Person
145 sg:person.01177540504.39 schema:affiliation https://www.grid.ac/institutes/grid.411728.9
146 schema:familyName Kaminska
147 schema:givenName Ewa
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177540504.39
149 rdf:type schema:Person
150 sg:person.01200213234.22 schema:affiliation https://www.grid.ac/institutes/grid.11866.38
151 schema:familyName Kaminski
152 schema:givenName Kamil
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200213234.22
154 rdf:type schema:Person
155 sg:person.01304442051.71 schema:affiliation https://www.grid.ac/institutes/grid.5603.0
156 schema:familyName Garbacz
157 schema:givenName Grzegorz
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304442051.71
159 rdf:type schema:Person
160 sg:pub.10.1007/s11095-010-0269-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004044325
161 https://doi.org/10.1007/s11095-010-0269-5
162 rdf:type schema:CreativeWork
163 sg:pub.10.1007/s11095-011-0496-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047079674
164 https://doi.org/10.1007/s11095-011-0496-4
165 rdf:type schema:CreativeWork
166 sg:pub.10.1023/a:1007516718048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017094560
167 https://doi.org/10.1023/a:1007516718048
168 rdf:type schema:CreativeWork
169 sg:pub.10.2165/00003088-200847100-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047478348
170 https://doi.org/10.2165/00003088-200847100-00003
171 rdf:type schema:CreativeWork
172 sg:pub.10.2165/00023210-200317060-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013429957
173 https://doi.org/10.2165/00023210-200317060-00004
174 rdf:type schema:CreativeWork
175 https://app.dimensions.ai/details/publication/pub.1077518548 schema:CreativeWork
176 https://app.dimensions.ai/details/publication/pub.1078633835 schema:CreativeWork
177 https://doi.org/10.1002/9783527623860.ch19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047281475
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1002/jps.21799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019762655
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1002/jps.22479 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051977655
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/j.ejpb.2008.05.029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026516251
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/j.ejps.2009.06.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011938329
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/j.ejps.2013.08.039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039065309
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/s0378-5173(98)00338-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1050042406
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1021/js9601896 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003304858
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1021/mp300067r schema:sameAs https://app.dimensions.ai/details/publication/pub.1056212845
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1021/mp300606p schema:sameAs https://app.dimensions.ai/details/publication/pub.1056213140
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1039/c3cp52643g schema:sameAs https://app.dimensions.ai/details/publication/pub.1015773196
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1080/14786435.2010.534742 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011684960
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1089/blr.2006.25.447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059238419
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1177/001857870103600612 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100243706
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1358/dof.1994.019.06.254341 schema:sameAs https://app.dimensions.ai/details/publication/pub.1065060842
206 rdf:type schema:CreativeWork
207 https://doi.org/10.14227/dt160209p6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067217438
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1517/17425247.2010.527943 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007294236
210 rdf:type schema:CreativeWork
211 https://doi.org/10.3109/03639040903311081 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009118497
212 rdf:type schema:CreativeWork
213 https://www.grid.ac/institutes/grid.11451.30 schema:alternateName Gdańsk Medical University
214 schema:name Department of Pharmaceutical Technology, Medical University of Gdansk, Hallera 107, 80-416, Gdansk, Poland
215 rdf:type schema:Organization
216 https://www.grid.ac/institutes/grid.11866.38 schema:alternateName University of Silesia
217 schema:name Institute of Physics, University of Silesia, Uniwersytecka 4, 40-007, Katowice, Poland
218 rdf:type schema:Organization
219 https://www.grid.ac/institutes/grid.411728.9 schema:alternateName Medical University of Silesia
220 schema:name Department of Pharmacognosy and Phytochemistry, Medical University of Silesia in Katowice, ul. Jagiellonska 4, 41-200, Sosnowiec, Poland
221 rdf:type schema:Organization
222 https://www.grid.ac/institutes/grid.5603.0 schema:alternateName University of Greifswald
223 schema:name Institute of Pharmacy, University of Greifswald, Felix-Hausdorf-Strasse 3a, 17489, Greifswald, Germany
224 Physiolution GmbH, Walther-Rathenau-Strasse 49 a, 17489, Greifswald, Germany
225 rdf:type schema:Organization
226 https://www.grid.ac/institutes/grid.5633.3 schema:alternateName Adam Mickiewicz University in Poznań
227 schema:name NanoBioMedical Centre, Adam Mickiewicz University, Umultowska 85, 61-614, Poznan, Poland
228 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...